Login / Signup

Digital process control of multi-step assays on centrifugal platforms using high-low-high rotational-pulse triggered valving.

Philip L EarlyNiamh A KilcawleyNiamh A McArdleMarine RenouSinéad M KearneyRohit MishraNikolay DimovMacdara T GlynnJens DucréeDavid J Kinahan
Published in: PloS one (2023)
Due to their capability for comprehensive sample-to-answer automation, the interest in centrifugal microfluidic systems has greatly increased in industry and academia over the last quarter century. The main applications of these "Lab-on-a-Disc" (LoaD) platforms are in decentralised bioanalytical point-of-use / point-of-care testing. Due to the unidirectional and omnipresent nature of the centrifugal force, advanced flow control is key to coordinate multi-step / multi-reagent assay formats on the LoaD. Formerly, flow control was often achieved by capillary burst valves which require gradual increments of the spin speed of the system-innate spindle motor. Recent advanced introduced a flow control scheme called 'rotational pulse actuated valves'. In these valves the sequence of valve actuation is determined by the architecture of the disc while actuation is triggered by freely programmable upward spike (i.e. Low-High-Low (LHL)) in the rotational frequency. This paradigm shift from conventional 'analogue' burst valves to 'digital' pulsing significantly increases the number of sequential while also improving the overall robustness of flow control. In this work, we expand on these LHL valves by introducing High-Low-High (HLH) pulse-actuated (PA) valving which are actuated by 'downward' spike in the disc spin-rate. These HLH valves are particularly useful for high spin-rate operations such as centrifugation of blood. We introduce two different HLH architectures and then combine the most promising with LHL valves to implement the time-dependent liquid handling protocol underlying a common liver function test panel.
Keyphrases
  • aortic valve
  • aortic valve replacement
  • blood pressure
  • immune response
  • high throughput
  • randomized controlled trial
  • single molecule
  • room temperature
  • aortic stenosis
  • left ventricular